Document Detail


Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
MedLine Citation:
PMID:  6849269     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Forty-five patients survived a cardiac arrest due to ventricular tachycardia (VT) or ventricular fibrillation (VF). Programmed ventricular stimulation was performed with the patients taking no antiarrhythmic medications. Sustained VT was induced in 26 patients (58%) and nonsustained VT in 8 (18%). With treatment aimed at the underlying heart disease (plus empiric antiarrhythmic therapy in 2 patients), the 11 patients who had no inducible VT have had no recurrence of symptomatic VT or cardiac arrest over a follow-up period of 19 +/- 9 months (mean +/- standard deviation). Conventional antiarrhythmic drugs suppressed the induction of VT and were used for chronic treatment in 9 of 34 patients (26%) with inducible VT. Three of these 9 patients had recurrent VT or sudden death, whereas 6 have had no recurrence over follow-up of 20 +/- 7 months. In the 25 of 34 patients in whom the induction of VT was not suppressed by conventional antiarrhythmic drugs, 23 were treated with amiodarone (daily dose 550 +/- 120 mg), and 2 underwent coronary artery bypass grafting with either aneurysmectomy or map-directed endocardial resection. One of the latter 2 patients died suddenly 12 months after surgery. Among the 23 patients treated with amiodarone, 2 had fatal VT or sudden death and 21 (91%) did not, over 18 +/- 14 months of follow-up. In survivors of a cardiac arrest, the chief value of electrophysiologic testing is in identifying patients without inducible VT, who appear to have a low risk of recurrent sudden death with treatment directed at the underlying heart disease. Serial electropharmacologic testing with conventional antiarrhythmic drugs is disappointing, with a low incidence of arrhythmia suppression.
Authors:
F Morady; M M Scheinman; D S Hess; R J Sung; E Shen; W Shapiro
Related Documents :
3626019 - Study on congenital complete heart block in children by 24-hour ambulatory electrocardi...
10760339 - Improved survival in patients with nonischemic advanced heart failure and syncope treat...
2330399 - Psychiatric syncope: a new look at an old disease.
19808409 - Ventricular tachycardia ablation: evolution of patients and procedures over 8 years.
12877699 - Patients with an icd can safely resume work in industrial facilities following simple s...
7885939 - Ventriculoatrial conduction in patients with implantable cardioverter defibrillators: i...
11681489 - The increased interleukin-13 in patients with systemic lupus erythematosus: relations t...
423069 - Ureterosigmoidostomy in childhood: the quality of life.
24776159 - Intermittent atrial undersensing in single-lead vdd pacemakers in patients with bradyca...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  51     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1983 Jan 
Date Detail:
Created Date:  1983-02-14     Completed Date:  1983-02-14     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  85-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Death, Sudden / etiology*
Electrophysiology
Female
Heart Arrest / complications,  physiopathology*
Humans
Male
Middle Aged
Patient Admission*
Procainamide / therapeutic use
Propranolol / therapeutic use
Recurrence
Tachycardia / complications,  drug therapy,  physiopathology
Chemical
Reg. No./Substance:
51-06-9/Procainamide; 525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Determinants of ventricular tachycardia in patients with coronary artery disease and ventricular ane...
Next Document:  Quinidine for ventricular arrhythmias: value of electrophysiologic testing.